|
Bartlett, M S; Queener, S F; Shaw, M M et al. (1997) In vitro and in vivo models of Pneumocystis carinii. J Eukaryot Microbiol 44:51S
|
|
Goheen, M P; Bartlett, M S; Shaw, M M et al. (1993) Effects of 8-aminoquinolines on the ultrastructural morphology of Pneumocystis carinii. Int J Exp Pathol 74:379-87
|
|
Goheen, M P; Blumershine, R; Bartlett, M S et al. (1992) Improved intracellular morphology of Pneumocystis carinii from rat lung by postfixation with a mixture of potassium ferrocyanide and osmium tetroxide. Biotech Histochem 67:140-8
|
|
Bartlett, M S; Fishman, J A; Queener, S F et al. (1988) New rat model of Pneumocystis carinii infection. J Clin Microbiol 26:1100-2
|
|
Bartlett, M S; Durkin, M M; Jay, M A et al. (1987) Sources of rats free of latent Pneumocystis carinii. J Clin Microbiol 25:1794-5
|
|
Bartlett, M S; Queener, S F; Jay, M A et al. (1987) Improved rat model for studying Pneumocystis carinii pneumonia. J Clin Microbiol 25:480-4
|
|
Queener, S F; Bartlett, M S; Jay, M A et al. (1987) Activity of lipid-soluble inhibitors of dihydrofolate reductase against Pneumocystis carinii in culture and in a rat model of infection. Antimicrob Agents Chemother 31:1323-7
|
|
Lee, C H; Bolinger, C D; Bartlett, M S et al. (1986) Production of monoclonal antibody against Pneumocystis carinii by using a hybrid of rat spleen and mouse myeloma cells. J Clin Microbiol 23:505-8
|
